| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 62.355 | 58.270 | 10.124 | 0 | -351 | 4.518 | 1.001 | 1.967 | 11.587 | 11.337 |
| Total Income - EUR | 62.364 | 59.023 | 15.051 | 0 | 397 | 4.518 | 1.001 | 1.968 | 11.587 | 11.337 |
| Total Expenses - EUR | 68.745 | 58.109 | 12.702 | 4.109 | 1.459 | 537 | 343 | 952 | 8.773 | 10.434 |
| Gross Profit/Loss - EUR | -6.381 | 914 | 2.349 | -4.109 | -1.063 | 3.982 | 658 | 1.016 | 2.814 | 903 |
| Net Profit/Loss - EUR | -6.381 | 902 | 1.131 | -4.109 | -1.068 | 3.846 | 628 | 996 | 2.708 | 563 |
| Employees | 4 | 4 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Pro Eurolife Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.478 | 9.087 | 6.731 | 2.498 | 2.164 | 1.843 | 1.528 | 1.258 | 179 | 307 |
| Current Assets | 19.148 | 6.679 | 5.558 | 5.456 | 1.552 | 4.839 | 1.210 | 2.059 | 4.719 | 5.114 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.894 | 947 | 3.351 | 3.289 | 0 | 0 | 1.001 | 1.987 | 1.981 | 0 |
| Cash | 13.254 | 5.732 | 2.207 | 2.166 | 1.552 | 4.839 | 209 | 72 | 2.738 | 5.114 |
| Shareholders Funds | -1.037 | -124 | 1.009 | -3.119 | -4.075 | -152 | 480 | 1.477 | 4.181 | 4.720 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 21.664 | 15.891 | 11.280 | 11.073 | 7.791 | 6.834 | 2.258 | 1.840 | 717 | 702 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Pro Eurolife Med Srl